Portrait of Dr. Michelle A Lane

Dr. Michelle A Lane

  • Associate Professor at School of Family & Consumer Sciences, College of Applied Arts

Grants

2022

  • Kornienko, Alexander Vladimir (Co-Principal), Percent Contribution: %50, Lane, Michelle A (Co-Principal), Percent Contribution: %50. Evaluation of 7-deazahypoxanthine derivatives as cancer chemotherapeutic agents, ORSP Research Accelerator, Texas State University, $20000. (Submitted: February 2022, Funded: February 2022 - May 2023). Grant.
  • Lane, Michelle A. Mouse Models of Advanced, Non-Resectable, Metastatic Stage 4 Colorectal Cancer, Research Enhancement Program, Texas State University, $8000. (Submitted: October 2021, Funded: February 2022 - May 31, 2023). Grant.

2018

  • Lane, Michelle A, Crixell, Sylvia L. Diet, BFNF, and BPA Exposure as Predictors for Postpartum Behavioral Impairment in Low Income Women, Research Enhancement Program, Texas State University, $16000. (Submitted: October 2017, Funded: January 2018 - Present). Grant.

2015

  • Lane, Michelle A (Principal). Developmental Leave Supplemental Grant Award, Texas State University, $20000. (Funded: September 1, 2015 - December 31, 2015). Grant.

2012

  • Lane, Michelle A (Principal). Treatment of depression with omega-3 fatty acids, Research Enhancement Program, Texas State University, $8000. (Funded: January 1, 2012 - August 31, 2012). Grant.

2009

  • Lane, Michelle A (Co-Principal). Role of human gut microflora in colon cancer metastasis, Research Enhancement Program, Texas State University, $16000. (Funded: January 12, 2009 - August 31, 2010). Grant.
  • Lane, Michelle A (Principal). Interaction between vitamin A and PI3K in colorectal tumor progression, American Institute for Cancer Research, $164921. (Funded: January 1, 2009 - December 31, 2011). Grant.

2007

  • Lane, Michelle A (Principal). Effect of Accutane on the serotonergic pathway, RoAccutane Foundation, $6600. (Funded: January 1, 2007 - December 31, 2008). Grant.

2006

  • Lane, Michelle A (Principal). Does retinol prevent colorectal cancer metastasis?, National Institutes of Health, National Cancer Institute, $312840. (Funded: December 1, 2006 - November 30, 2009). Grant.

2004

  • Lane, Michelle A (Principal). Does Accutane cause depression?, University of Texas at Austin Fiscal Year Research Grants, $5645. (Funded: September 1, 2004 - August 31, 2005). Grant.

2003

  • Lane, Michelle A (Principal). Retinol inhibition of retinoic acid-resistant colon cancer cell growth, American Cancer Society, $710000. (Funded: July 1, 2003 - June 30, 2007). Grant.

2002

  • Lane, Michelle A (Principal). Research Internship, The University of Texas at Austin, $16000. (Funded: September 2, 2002 - May 31, 2003). Grant.
  • Lane, Michelle A (Principal). Retinol metabolism and signaling in colon cancer, Summer Research Award, The University of Texas at Austin, $12000. (Funded: June 1, 2002 - August 31, 2002). Grant.
  • Lane, Michelle A (Principal). Role of retinol in colon cancer treatment, Human Ecology Indirect Cost Funds, The University of Texas at Austin, $6000. (Funded: June 1, 2002 - August 31, 2002). Grant.

1998

  • Lane, Michelle A (Principal). Postdoctoral Fellowship: 4-Oxoretinol: potential new chemotherapeutic agent, National Institutes of Health, National Cancer Institute, $108342. (Funded: August 10, 1998 - July 31, 2001). Grant.

1994

  • Lane, Michelle A (Principal). Robert White-Stevens Graduate Fellowship in Nutrition, Robert White-Stevens Foundation, $16000. (Funded: 1994 - 1996). Grant.